REGENTS OF THE UNIVERSITY OF CALIFORNIA - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
REGENTS OF THE UNIVERSITY OF CALIFORNIA ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,523,733
-22.5%
111,4400.0%0.45%
-20.6%
Q2 2023$4,544,523
+9.4%
111,4400.0%0.57%
-26.3%
Q1 2023$4,153,369
+6.8%
111,4400.0%0.77%
+4.7%
Q4 2022$3,888,142
-37.7%
111,4400.0%0.74%
-41.7%
Q3 2022$6,236,000
+8.1%
111,4400.0%1.26%
+9.3%
Q2 2022$5,768,000
-28.8%
111,4400.0%1.16%
-4.9%
Q1 2022$8,098,000
-38.5%
111,4400.0%1.22%
-34.1%
Q4 2021$13,177,000
-11.9%
111,4400.0%1.85%
+4.9%
Q3 2021$14,950,000
-17.1%
111,4400.0%1.76%
-23.6%
Q2 2021$18,043,000
+101.7%
111,4400.0%2.30%
+97.5%
Q1 2021$8,944,000
+47.5%
111,4400.0%1.17%
+33.1%
Q4 2020$6,062,000
+173.7%
111,4400.0%0.88%
+184.4%
Q3 2020$2,215,000
-5.4%
111,4400.0%0.31%
-6.4%
Q2 2020$2,342,000
+71.8%
111,4400.0%0.33%
+62.1%
Q1 2020$1,363,000
-16.6%
111,4400.0%0.20%
-76.5%
Q4 2019$1,635,000
+9.9%
111,4400.0%0.86%
-69.7%
Q3 2019$1,488,000
-18.4%
111,4400.0%2.85%
-44.7%
Q2 2019$1,824,000
-83.5%
111,440
-78.7%
5.15%
-80.2%
Q1 2019$11,060,000
+54.5%
524,4230.0%26.04%
+50.4%
Q4 2018$7,158,000
-52.3%
524,4230.0%17.31%
-40.7%
Q3 2018$15,009,000
+4.6%
524,4230.0%29.21%
-22.2%
Q2 2018$14,348,000
+29.7%
524,4230.0%37.54%
+85.2%
Q1 2018$11,060,000
+9.7%
524,4230.0%20.28%
+33.4%
Q4 2017$10,079,000524,42315.19%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders